A growing, sourced collection of publicly documented stories about how non-intoxicating CBD, CBG, and other legal cannabinoids fit into real lives — gathered to put human faces on the 2026 hemp-law debate. Every entry links to its original public source.
"He's been seizure-free for 10 years… on a non-intoxicating product."
After brain surgery and multiple pharmaceuticals failed to control Reagan's epilepsy, the family turned to CBD in 2014. He has been seizure-free for roughly a decade and the family now fears losing access.
"She went seven days without a seizure — down from nearly 300 a week."
The child whose response to CBD oil, featured in Dr. Sanjay Gupta's CNN documentary "Weed," catalyzed a national movement for CBD access. April 7 is recognized by some as "Charlotte Figi Day."
"We celebrated her one-year seizure-free versary… a remarkable milestone."
Sadie, who has Rett syndrome with seizures, insomnia, and anxiety, uses a doctor-recommended CBD tincture with trace THC. Her mother worries a ban removes the specific product and dose that works.
"Nothing worked until she tried CBD… clearing an attack in 15 minutes."
Brooke's Dravet-related seizures can last 25–45 minutes. Daily CBDV and full-spectrum CBD oil reduce their frequency and duration; the family stocked up amid regulatory uncertainty.
"A fellow patient mentioned CBD oil… it gave her hope when she was suicidal from uncontrolled seizures."
KFF Health News documented how patients with forms of epilepsy outside Epidiolex's approved indications navigate the CBD market "at the mercy and trust of the grower" — underscoring the need for regulation, not prohibition.
"It's not uncommon for a veteran to take 10,000 pills a year. This helps us to function."
Veterans have testified that regulated hemp products offer a safer alternative to large prescription-drug regimens for PTSD and pain, and warn that bans remove a tool they rely on.
"CBD transformed him from hospice to health."
An op-ed from the nonprofit Realm of Caring describes children for whom conventional medicines failed finding relief with CBD, and reports that caregivers see fewer ER visits and missed school days.
"20 mg of hemp-derived CBG significantly reduced anxiety — without intoxication."
The first human clinical trial of CBG found measurable reductions in anxiety and stress vs. placebo, with no impairment and even improved verbal memory — early but rigorous evidence for a non-intoxicating cannabinoid.
"Evidence supports CBD's potential across GAD, panic, social anxiety, OCD, and PTSD."
A widely cited scientific review synthesized preclinical and human data pointing to CBD's anxiolytic potential — strongest for acute dosing, with a call for more long-term clinical trials.
"The first and only FDA-approved prescription CBD for seizures."
Regulator-backed proof that purified CBD reduces seizures in Lennox-Gastaut, Dravet, and tuberous sclerosis complex — the scientific anchor of the case that CBD is legitimate medicine, not a "loophole."